SCHEMBL2253045

SCHEMBL2253045

O=C(O)c1ccc(-c2ccc(F)cc2)cc1C=Cc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 2/20 0.70
BAD Q92934 1/20 0.70
DHODH Q02127 4/20 0.51
XDH P47989 2/20 0.47
MCL1 Q07820 2/20 0.46
TRPM2 O94759 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42
TUBB8 Q3ZCM7 1/20 0.42
TUBA3E Q6PEY2 1/20 0.42
TUBA1A Q71U36 1/20 0.42
TUBA1C Q9BQE3 1/20 0.42
TUBB6 Q9BUF5 1/20 0.42
TUBB2B Q9BVA1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253039 1.00 BCL2L1 (0.70) BCL2L1BADDHODHXDHMCL1
SCHEMBL2254969 0.93 BCL2L1 (0.67) BCL2L1BADDHODHXDHMCL1
SCHEMBL2254966 0.93 BCL2L1 (0.67) BCL2L1BADDHODHXDHMCL1
SCHEMBL2252464 0.91 BCL2L1 (0.74) BCL2L1BADDHODHXDHMCL1
SCHEMBL2252460 0.91 BCL2L1 (0.74) BCL2L1BADDHODHXDHMCL1
SCHEMBL2256914 0.90 BCL2L1 (0.85) BCL2L1BADDHODHMCL1TRPM2
SCHEMBL2255686 0.90 BCL2L1 (0.85) BCL2L1BADDHODHTRPM2MEN1
SCHEMBL2255687 0.90 BCL2L1 (0.85) BCL2L1BADDHODHTRPM2MEN1
SCHEMBL2256911 0.90 BCL2L1 (0.85) BCL2L1BADDHODHMCL1TRPM2
SCHEMBL2254358 0.88 BCL2L1 (0.77) BCL2L1BADTRPM2TRPA1SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885DHODH 2641/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885DHODH 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.